红日超思轻量化智能多参数检测仪入围工信部“揭榜挂帅”项目

Core Insights - The Ministry of Industry and Information Technology announced the list of units selected for the "2025 Artificial Intelligence Medical Device Innovation Task," with Tianjin Chaosi Medical Instrument Co., Ltd. leading a project focused on a lightweight intelligent multi-parameter detection device driven by multimodal biological signals and AI [1] Group 1: Product Innovation - The core product, a lightweight intelligent multi-parameter detection device, integrates several breakthrough technologies, allowing blood pressure monitoring without a cuff, using only brief contact with the thumbs [2] - The device achieves medical-grade accuracy in ECG detection, with sensitivity and specificity for atrial fibrillation exceeding 94%, enabling early home screening for heart issues [2] - It combines blood pressure, blood oxygen, and ECG monitoring into one compact device, ensuring ease of use and no need for recalibration [2] Group 2: Research and Development Strength - The successful selection for the project reflects the solid R&D foundation of Chaosi, which has received authoritative recognition for its research capabilities [3] - Chaosi's invention patent for a non-invasive, high-precision respiratory rate measurement method recently won the 2025 Tianjin Patent Excellence Award, enhancing measurement reliability in complex environments [3] - The company has nearly 200 global patents, supported by a systematic intellectual property and R&D innovation framework, bolstered by collaboration with Harbin Institute of Technology [3] Group 3: Market Expansion - Chaosi's strong R&D capabilities have driven product line expansion and market growth, creating a comprehensive product ecosystem focused on multi-parameter, intelligent, and systematic health solutions [4] - The product matrix covers key areas of blood oxygen, respiration, and cardiovascular health, with over a hundred models in blood oxygen monitoring [4] - Recently, portable and smart medical oxygen machines from Chaosi received CE-MDR certification, allowing entry into all 27 EU member states, demonstrating international competitiveness in R&D, manufacturing, and quality management [4]